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Abstract We have expressed [U-13C,15N]-labeled Saccharo-
myces cerevisiae iso-1 cytochrome c C102T;K72A in Escherichia
coli with a yield of 11 mg/l of growth medium. Nuclear magnetic
resonance (NMR) studies were conducted on the Fe3+ form of the
protein. We report herein chemical shift assignments for amide
1H and 15N, 13C‡, 13CK, 13CL, 1HK and 1HL resonances based
upon a series of three-dimensional NMR experiments: HNCA,
HN(CO)CA, HNCO, HN(CA)CO, HNCACB, HCA(CO)N,
HCCH-TOCSY and HBHA(CBCA)NH. An investigation of
the chemical shifts of the threonine residues was also made by
using density functional theory in order to help solve discrepan-
cies between 15N chemical shift assignments reported in this
study and those reported previously. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Low expression levels of yeast iso-1 cytochrome c (cyt c)
have precluded the ready isotopic incorporation of 13C labels
for nuclear magnetic resonance (NMR) spectroscopy. A lim-
ited number of 13C assignments have previously been reported
for ferrocytochrome c using measurements made on concen-
trated samples at natural abundance [1], but previous struc-
tural studies of ferricytochrome c have relied on 1H NMR
data (assignments [2], NOEs and pseudocontact shifts [3]),
and despite low yields, 15N-labeled ferricytochrome c has
been prepared for hydrogen exchange and dynamics measure-
ments by using large-scale fermentation [4^6]. However, the
construction by Pollock et al. [7] of a plasmid which encodes
the coexpression of cyt c heme lyase has recently permitted the
expression of the yeast protein in Escherichia coli, with much
higher yields. The protein expressed in E. coli lacks the post-
translational modi¢cation (trimethylation) of K72 and,
though spectroscopically equivalent at pH 7, has a slightly
lower pKa for the alkaline conformational transition than
that obtained from yeast. The C102T;K72A mutant, which
is more stable at mildly alkaline pH, has been engineered by
Mauk and coworkers [7] and is the subject of this investiga-
tion. While this work was in progress, Pielak et al. have also
made use of a similar expression system to express 15N-labeled
ferricytochrome c C102T [8], to study 1H and 15N hyper¢ne
shifts [9].
The desire to incorporate additional spectroscopic restraints
into a solution structure determination prompted us to ex-
press [U-13C,15N]-labeled yeast iso-1 cyt c in E. coli in order
to provide a data base of dipolar splittings [10], 1H, 13C and
15N NMR shifts [11] and shift anisotropies [12], to be used in
structure re¢nement, using in some cases quantum chemical
techniques. It has been shown previously that quantum chem-
istry can be used to predict 1H, 13C, 15N and 19F chemical
shifts in proteins [13], and that 15N shifts are dependent pri-
marily on local backbone dihedral angles, Pi and ii31 [14].
Here, in addition to providing most backbone 1H, 13C and
15N shifts, together with those of CL, we demonstrate that
quantum chemical (density functional theory (DFT)) calcula-
tions can be used to validate spectroscopic assignments, which
can be of particular utility when di¡erences between assign-
ments from di¡erent groups are apparent.
2. Materials and methods
2.1. Protein expression and puri¢cation
The plasmid for Saccharomyces cerevisiae iso-1 cyt c K72A;C102T,
pBTR2, was the kind gift of Professor A.G. Mauk. Freshly trans-
formed E. coli cells (Epicurian coli BL21(DE3) Gold competent cells,
Stratagene, La Jolla, CA, USA) were spread on an LB-ampicillin
plate and incubated at 37‡C overnight. A single colony from the plate
was used to inoculate 5 ml of LB [15]. After overnight incubation at
37‡C and 220 rpm, 50 Wl of culture was used to inoculate 50 ml of
growth medium, which was similarly incubated and shaken until mid-
log phase (5^6 h). This culture was then used as a 1% inoculation for
600 ml of medium, which was ¢rst incubated at 37‡C and 200 rpm for
18 h and then at 150 rpm for 4 h, prior to harvesting the cells. All
growth media were supplemented with 0.2 mg/ml ampicillin (Sigma,
St. Louis, MO, USA).
The puri¢cation scheme was loosely based on that described by
Mauk and coworkers [7]. The cell paste was ¢rst £ash frozen in dry
ice. Then, lysis was achieved by stirring the cell paste in three times its
volume of Bacterial Protein Extraction Reagent (Pierce, Chemical
Co., Rockford, IL, USA) containing 1 mM EDTA, 1 mM PMSF,
40 U/ml DNase, 4 U/ml RNase and 3 mg/ml lysozyme, at room
temperature. Subsequent puri¢cation steps were conducted at 4‡C.
After ultracentrifugation, the cell pellet was redissolved in lysis bu¡er
and centrifuged. The supernatants from each lysis were combined and
subjected to fractionation with a 55% saturated (NH4)2SO4 solution.
The protein solution was centrifuged and the supernatant dialyzed
against 46 mM NaPi, pH 6.8. The resulting dialysate was then loaded
onto a CM52 cation exchange column (Whatman International Ltd.,
Maidstone, UK), which was equilibrated with the same bu¡er. The
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protein was eluted with equilibration bu¡er containing 250 mM NaCl.
Fractions which were s 80% pure, as determined by UV-vis absorp-
tion [16] and SDS^polyacrylamide gel electrophoresis, were combined
and exchanged with 46 mM NaPi, pH 6.8. The protein solution was
then loaded onto a CM52 column that had been equilibrated with
20 mM NaPi, pH 7.0. The protein was eluted with equilibration bu¡er
with a linear [NaCl] gradient, from 0 to 300 mM. Those fractions that
were s 95% pure were combined, exchanged with 50 mM NaPi, pH
7.0, and concentrated using a YM-3 (Amicon, Beverly, MA, USA)
membrane in an Amicon stirred cell, followed by 3000 MWCO Cen-
tricon and Microcon centrifugal concentrators (Millipore Corpora-
tion, Bedford, MA, USA).
13C,15N-labeled protein was expressed by growing cells in an iso-
topically labeled growth medium at the 50 ml and 0.6 l scales, using a
mixture of a modi¢ed M9 minimal medium [17] and Celtone-CN
(Martek Biosciences Corporation, Columbia, MD, USA) in a 6:4
ratio. Electrospray mass spectrometry data indicated essentially com-
plete isotopic labeling (experimental mass = 13 296 Da, theoretical
mass = 13 334 Da). (15NH4)2SO4, 15NH4Cl and [U-13C]glucose were
from Cambridge Isotope Laboratories (Andover, MA, USA).
2.2. NMR spectroscopy
Puri¢ed protein was oxidized with a slight excess of K3Fe(CN)6,
which was then removed by exchanging with 50 mM NaPi, pH 7.0.
D2O (Aldrich, Milwaukee, WI, USA) was added to a ¢nal concen-
tration of 10% by volume. The ¢rst sample was 0.5 mM in cyt c, and
was used for the majority of the experiments; a second sample was
prepared at 1.5 mM, and yielded indistinguishable NMR chemical
shifts.
A suite of sensitivity-enhanced three-dimensional (3D) triple reso-
nance experiments were performed by using a Varian (Palo Alto, CA,
USA) Inova 17.6 T NMR spectrometer. A Varian 5 mm 1H{13C,15N}
pulsed ¢eld gradient probe was utilized, and the temperature was
regulated to 38 þ 1‡C. The following experiments were used for se-
quential resonance assignments: HNCO [18], HN(CA)CO [19],
HNCA [20], HN(CO)CA [19] and HNCACB [21]. Spectral parameters
were as follows: a recycle delay of 0.6 s was used in each experiment.
Typical spectral widths were 13 502, 2280, 2264, 6855 and 11 053 Hz
for the 1H, 15N, 13C‡, 13CK and 13CK-13CL regions, and 90‡ pulse
widths were 7 Ws for 1H, 12.4 Ws for 13C and 35 Ws for 15N. Other
experimental conditions were as follows: the HNCO experiment was
acquired with 2048U52U64 data points in each of the 1H, 13C and
15N dimensions, respectively, with 32 scans per FID, yielding a total
acquisition time of 92 h; HN(CA)CO: 2048U89U32 (1H, 13C, 15N)
data points, 32 scans (110 h); HNCA: 2048U86U40 (1H, 13C, 15N)
data points, 32 scans (92 h); HN(CO)CA: 2048U60U32 (1H, 13C,
15N) data points, 16 scans (26 h); HNCACB: 2048U50U32 (1H, 13C,
15N) data points, 32 scans (43 h). Proton chemical shifts were refer-
enced to external DSS (dimethylsilapentane-5-sulfonic acid, Thomp-
son Packard, Inc., Little Falls, NJ, USA), and the 13C and 15N chem-
ical shifts were indirectly referenced using the ‘consensus’ 7 ratios, as
described by Wishart et al. [22]. The N-scale, in which high frequency,
low-¢eld, paramagnetic or deshielded values are positive, was used.
Data were processed using Felix 98.0 (Molecular Simulations, Inc.,
San Diego, CA, USA) on a Silicon Graphics (SGI, Mountain View,
CA, USA) Origin 200 workstation. Suppression of the residual water
signal was achieved by post-acquisition time-domain convolution with
a sinebell function. The down¢eld half of the directly detected 1H
dimension (amide region) was extracted for further processing. Linear
prediction was used to extend the number of data points in the in-
directly detected 13C and 15N dimensions by a factor of two, then
zero-¢lling was used to yield a 1024U256U128 point matrix in the
1H, 13C and 15N dimensions, respectively. A 90‡ phase-shifted
(sinebell)2 apodization function was applied over all acquired and
linear predicted data points. A two-dimensional (2D) 15N-1H HSQC
spectrum [23] with WET [24] solvent suppression was acquired with
1H and 15N spectral widths of 16 502 Hz and 4561 Hz, respectively.
The data consisted of 128 points in t1 and 2048 points in t2, and 16
scans per FID. Processing conditions were as described above. An
expansion of the HSQC spectrum is shown in Fig. 1. A 3D HCA(-
CO)N experiment [25] was performed in 57 h (sweep width (Hz),
number of increments: 7502, 1152 (1H); 4605, 30 (13C); 2824,
72 (15N)) with 32 scans per FID. Processing parameters were identical
to those described above, except that the full 1H spectrum was used,
and zero-¢lling was applied such that the resulting matrix contained
1024U128U256 data points in the 1H, 13C and 15N dimensions, re-
spectively. A 3D HCCH-TOCSY [26] data set was acquired in 81 h
(2048U104U60 data points with 13502, 13502 and 12941 Hz spectral
windows in the observed 1H, indirectly detected 1H, and 13C dimen-
sions, respectively). A 3D HBHA(CBCA)NH [27] data set was ac-
quired in 63 h (2048U70U32 data points with 13502, 10499 and
2500 Hz spectral windows in the observed 1H, indirectly detected
1H, and 15N dimensions).
2.3. Computational aspects
DFT calculations of threonine 15N chemical shieldings were per-
formed by using the gauge-including atomic orbitals approach [28,29]
in the Gaussian 98 [30] program (Gaussian, Inc., Pittsburgh, PA,
USA). An N-formyl-L-alanyl-threonine amide model fragment was
energy-minimized using an AMBER force¢eld [31,32] in the Discover
module of Insight II0 (Molecular Simulations, Inc., San Diego, CA,
USA). Following minimization, the Pi31, ii31, Pi and ii torsion
angles were set to the X-ray values, while the M1 angle was set to the
staggered minimum energy conformer (M1 = 60, 360 or 180) nearest to
the X-ray M1 value [33]. A locally dense [34] basis set approach was
employed using a 6-311++G(2d,2p)/6-31G scheme, with the larger
basis placed on the atoms in bold depicted in the following structure:
DFT calculations employed the Becke 1988 exchange functional [35]
and the Perdew/Wang 1991 correlation functional [36] (BPW91). Cal-
culations were carried out by using Silicon Graphics Origin 200 com-
puters in this laboratory as well as on Silicon Graphics Origin 2000
and HP-Convex Exemplar SP-2000 (Hewlett Packard Company, Palo
Alto, CA, USA) computers, located in the National Center for Super-
computing Applications in Urbana, IL, USA. The experimental threo-
nine torsion angles employed in these calculations were obtained from
the Research Collaboratory for Structural Bioinformatics Protein
Data Bank [37], for the following proteins: bovine pancreatic trypsin
inhibitor (5pti) [38], ubiquitin (1ubq) [39] and cyt c (2ycc) [40].
3. Results and discussion
Previous expression methods made use of the yeast strain
C93, which produced yeast cyt c C102T in yields of 0.4 mg per
liter of growth medium [4]. The expression system for this
protein in E. coli developed by Mauk and coworkers [7] has
recently been used for the production of 15N-labeled protein
in much higher yields (8 mg/l) [8], which makes the prepara-
tion of doubly labeled proteins feasible. We have used a sim-
ilar system in E. coli to express doubly labeled cyt c
C102T;K72A. Using our mixture of modi¢ed M9 minimal
medium and Celtone, we obtained 14 mg/l of [U-15N]-labeled
and 11 mg/l of [U-13C,15N]-labeled cyt c.
The combination of the HNCA, HN(CO)CA, HNCACB,
HNCO and HN(CA)CO experiments allowed for the sequen-
tial assignment of backbone 1H and 15N, 13C‡, 13CK and 13CL
chemical shifts. Previous 1H and 15N assignments [2,5], to-
gether with a comparison of the primary sequence with 13CK
and 13CL shift patterns, facilitated initial residue-speci¢c
chemical shift assignments, while the HCA(CO)N, HCCH-
TOCSY and HBHA(CBCA)NH experiments permitted the
elucidation of 1HK and 1HL chemical shifts. Fig. 2 shows a
representative HNCACB strip plot, which illustrates the se-
quential connectivities between residues 31 and 44. Table 1
lists the speci¢c 1H, 15N and 13C chemical shift assignments
for cyt c. The ¢rst two residues of the sequence, together with
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Gly83 and Gly84 (except for G84:HK), remain to be assigned,
despite the e¡orts of several groups [2,3,5]. The double-Gly is
within a region near the connection between loop D and the
terminal helix C, for which we currently lack assignments for
reasons that are at this time unknown.
The amide 1H and 15N chemical shifts presented here are in
general agreement with those reported by Fetrow and Baxter
[5], with the exception of the 15N shifts corresponding to
residues: 19, 21, 23, 56, 72, 73, 75, 79, 80, 81 and 102, where
there are typically shift di¡erences of V2 parts per million
(ppm). However, in the cases of Thr19 and Thr102, the shift
di¡erences are 18.5 and 24.0 ppm, respectively. Of the 11
variant shifts, the more recent assignments by Pielak et al.
[8] show amide 15N chemical shifts for Thr19, Asn56, Lys79,
Ala81 and Thr102 which are in very close agreement with the
results we have obtained. One possibility for the discrepancies
is that the peak at 102.6 ppm, which we assign to 15NH of
Thr102, may have been folded in the 15N NOESY-HSQC
spectra of the initial study, based on the reported spectral
width in the 15N dimension (1250 Hz at 11.7 T, centered at
118.5 ppm; 106.2^130.8 ppm). If this peak was in fact folded,
it would place the actual 15N resonance at 101.9 ppm, which is
only 0.7 ppm up¢eld of the assignment presented here and 0.2
ppm up¢eld of that shown in the spectrum of Pielak et al. [8].
We veri¢ed that the peaks were not folded in our spectra by
acquiring 2D 15N-1H planes in the HNCACB experiment with
a larger spectral width (up to 100 ppm) and with di¡erent 15N
carrier frequencies (115.0 and 106.0 ppm). The discrepancy
between the 15NH assignment of Thr19 does not seem to be
due to folding. However, there does appear to be an unas-
signed crosspeak in the original 15N HSQC spectrum at V10
ppm (N1H) and 110 ppm (N15N) which may correspond to
Thr19 [4]. Such an assignment would then be in agreement
with the assignment by Pielak et al. [8] and that obtained here.
The crosspeaks corresponding to Thr19 and Thr102 are la-
beled in the 2D 15N-1H HSQC spectrum shown in Fig. 1. The
additional mutation at residue 72 (K72A) in the protein we
have investigated may account for the small di¡erences in
chemical shift seen for residues 72, 73 and 75 from those
reported previously, due to near-neighbor e¡ects.
In previous work [13,33,41,42], we have had some success in
predicting chemical shifts in proteins and peptides using quan-
tum chemical techniques. We therefore extended these meth-
ods here by using DFT calculations to investigate the s 18
ppm discrepancies in our backbone amide 15N shifts of Thr19
and Thr102 with those reported previously [5], basically to
test the idea that DFT calculations may be of use in con¢rm-
ing, or clarifying, spectroscopic assignments. For this we
chose two proteins, BPTI and ubiquitin, which are well-char-
acterized by both NMR and X-ray crystallography, to serve
as a small data base to check the accuracy of 15N NMR
shielding calculations for threonine residues. The theoretical
chemical shielding results from DFT calculations for these
two proteins, and for cyt c, were then compared with the
experimental NMR chemical shift results for BPTI [43], ubiq-
uitin [44] and the cyt c results from this work. We found a
good correlation between the experimental shifts and theoret-
ical shieldings for the two reference proteins (BPTI, ubiquitin)
with a slope of 30.75 and an R2 of 0.86, as shown in Fig. 3
(a). For BPTI and ubiquitin, the threonine M1 torsion angles
determined via X-ray [38,39] agree with the values found in
the well-de¢ned, high resolution NMR structures [45,46] with
the exception of ubiquitin Thr14. For the Thr14 calculation,
the M1 angle was therefore rotated from +60 (X-ray) to 360
(solution). This modi¢cation removed Thr14 as an outlier and
improved the theory vs. experiment slope and correlation. We
also show in Fig. 3 the experimental shifts/computed shield-
ings for the eight threonines in cyt c, based on the assignments
presented in Table 1 and the crystallographic coordinates for
yeast iso-1 cyt c. Seven of the eight cyt c points (R) fall very
near the BPTI/ubiquitin correlation line, while the datum for
Thr8 falls o¡ the line (predicted shielding = 137.9 ppm). How-
ever, if the M1 torsion angle of Thr8 is likewise changed from
+60 to 360, this point now falls very close to the correlation
line (U, predicted shielding = 126.2 ppm), suggestive of a crys-
Fig. 1. An expansion of the 2D 15N-1H HSQC spectrum at 38‡C.
See text for details.
Fig. 2. Strip plot of the 3D HNCACB experiment showing 2D 1H-13C planes at the given 15N frequency, with arrows showing the i to i+1
connectivities. The solid arrows show connectivities between 13CK resonances, and the dashed arrows correspond to those between 13CL reso-
nances.
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Table 1
Chemical shift assignments of yeast iso-1 cyt c C102T;K72A, pH 7.0, 311 K in 50 mM NaPi, with external DSS as a 1H shift reference (0.0
ppm)
Residue Amide 1H Amide 15N 13C‡ 13CK 13CL 1HK, 1HK2 a 1HL1, 1HL2 a
Glu34 175.6 56.2 30.8 4.31 2.0
Phe33 8.53 124.0 174.5 58.6 39.6 4.34 2.87, 2.63
Lys32 6.65 127.0 173.3 54.7 34.3 3.82 1.28, 1.42
Ala31 7.61 122.3 178.2 53.3 18.7 3.64 1.24
Gly1 8.02 110.2 173.0 43.9 4.31, 3.42
Ser2 9.37 119.6 175.5 55.6 63.1 4.74 3.82, 3.61
Lys4 179.3 59.7 4.01
Lys5 7.68 119.9 180.5 58.4 32.1 4.08 1.71
Gly6 8.65 107.4 174.2 47.1 4.00, 3.28
Ala7 7.97 124.9 180.5 54.8 18.5 2.40 1.20
Thr8 7.20 115.5 177.2 66.5 68.4 3.88 4.18
Leu9 7.82 123.6 177.8 58.1 42.8 3.81 1.82, 0.84
Phe10 8.61 120.1 178.6 62.9 40.0 3.49 2.74, 2.96
Lys11 8.40 120.5 177.7 60.2 32.7 4.30 2.13
Thr12 7.84 107.3 176.7 64.0 70.4 4.36 4.22
Arg13 8.20 116.1 176.8 55.5 31.3 4.6 1.43, 1.07
Cys14 7.87 114.3 177.7 55.3 37.4 4.72 2.71, 1.4
Leu15 7.95 123.2 177.3 58.0 44.0 5.91 2.47, 2.08
Gln16 9.88 117.6 177.6 59.4 28.8 4.72 2.63, 2.43
Cys17 9.58 113.4 176.1 58.1 37.2 6.03 2.47
His18 10.78 119.5 175.8 40.2 8.6
Thr19 9.88 110.1 176.4 60.9 72.7 6.14 5.37
Val20 8.46 110.5 174.3 62.4 34.2 4.81 2.15
Glu21 9.24 119.4 178.1 57.6 30.2 4.46 2.19
Lys22 8.79 125.9 178.1 58.7 31.5 3.38 1.5, 0.7
Gly23 9.37 117.9 174.9 45.5 4.06, 3.63
Gly24 8.26 108.6 170.8 44.5 4.37, 3.65
Pro25 179.4 62.6 32.1
His26 8.64 121.1 175.8 56.2 30.8 5.01 3.08, 2.75
Lys27 8.27 125.4 176.0 55.9 32.6 4.69 2.4, 2.1
Val28 7.41 121.5 176.2 65.8 32.9 3.12 1.3
Gly29 7.54 102.9 168.8 38.3 32.84, 30.10
Pro30 178.0 60.5 29.9 3.81 1.4, 30.1
Asn31 11.63 127.4 176.8 56.3 41.0 5.68 2.87, 2.49
Leu32 9.32 122.3 175.4 54.4 44.1 4.70 2.2, 1.9
His33 8.00 119.8 178.3 61.4 29.2 4.00
Gly34 8.95 115.8 175.2 46.4 3.78, 3.76
Ile35 7.14 116.1 174.1 61.5 37.9 3.66 1.64
Phe36 7.88 116.1 176.9 60.7 36.6 4.08 2.89
Gly37 8.75 110.1 173.1 45.1 4.27, 3.65
Arg38 7.93 121.1 174.7 54.7 33.3 4.47 1.98, 1.8
His39 8.01 118.7 177.0 57.2 30.9 5.15 2.92, 2.75
Ser40 8.66 115.8 175.2 58.7 63.8 4.52 4.16, 3.61
Gly41 8.91 109.5 174.6 45.5 3.10, 1.12
Gln42 7.80 112.9 176.4 55.1 30.3 4.47 2.42, 1.69
Ala43 8.09 124.2 178.2 54.1 18.7 4.34 1.42
Glu44 8.71 125.1 178.7 57.9 29.9 4.12 2.07
Gly45 172.8 45.9 4.27, 3.70
Tyr46 6.94 119.3 173.4 57.2 39.0 3.68 1.64, 0.63
Ser47 6.39 122.1 171.4 55.9 61.5 4.08 3.17, 3.00
Tyr48 7.64 124.8 178.9 58.5 41.6 4.16 3.29, 2.50
Thr49 9.62 112.0 176.0 62.6 71.1 4.17 4.60
Asp50 8.54 120.6 178.7 57.3 40.4 4.35 2.63, 2.56
Ala51 7.92 119.5 179.6 55.6 18.9 4.09 1.59
Asn52 8.28 117.7 178.3 56.1 40.4 4.67 3.14, 2.91
Ile53 7.61 120.6 178.6 65.3 39.3 3.65 1.86
Lys54 8.96 119.2 177.8 58.1 32.2 3.94 1.86
Lys55 7.36 118.3 176.8 57.3 31.5 4.07 2.01
Asn56 7.24 112.1 174.1 54.2 37.7 4.36 3.02, 2.3
Val57 7.27 113.9 173.7 59.6 33.6 4.12 1.36
Leu58 8.12 127.4 176.8 53.8 41.3 3.81 1.49, 0.86
Trp59 7.93 128.0 176.2 58.2 29.9 4.91 3.58, 2.38
Asp60 9.72 125.1 175.0 52.5 42.9 4.82 3.0, 2.8
Glu61 9.99 116.7 177.4 61.6 29.0 3.41 1.35
Asn62 8.16 116.1 178.3 56.3 38.8 4.45 2.88
Asn63 9.42 121.7 179.4 56.2 36.7 4.57 3.2, 2.9
Met64 8.71 121.1 177.9 57.6 30.6 4.35 2.2, 1.75
Ser65 7.47 113.6 177.4 61.7 62.9 3.57 4.14, 3.86
Glu66 7.63 121.0 179.8 60.3 29.5 3.87 2.08, 1.97
Tyr67 8.35 122.0 177.0 60.9 39.3 4.15 3.29, 3.04
Leu68 8.08 112.6 177.4 55.7 41.1 2.96 1.10, 0.15
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tal solution structural di¡erence, as deduced previously for
¢ve of the seven valine residues in calmodulin [33]. These
conformational changes are also supported by the 13CK chem-
ical shielding values, which improve for both ubiquitin Thr14
and cyt c Thr8 upon M1 rotation, resulting in an R2 = 0.71
versus R2 = 0.63, further supporting these small conformation-
al di¡erences between the X-ray and solution NMR struc-
tures.
The root mean square deviation for the full set of 18 calcu-
lated points is 2.4 ppm (slope =30.73, R2 = 0.78, Fig. 3). In
sharp contrast, the use of the earlier assignments for Thr19
and Thr102 clearly leads to pronounced deviations for these
two residues (of 14.7 ppm and 15.4 ppm, respectively) from
the correlation line. The slope and intercept of the BPTI/ubiq-
uitin correlation line can also be used to convert the predicted
absolute shieldings (the shielding from the bare nitrogen
atom) computed via DFT to chemical shifts, in which case
we ¢nd predicted shifts of 109.0 ppm and 105.0 ppm for
Thr19 and Thr102, in very good accord with the 110.5 and
102.6 ppm values seen experimentally. This is consistent with
both our assignments and those reached independently by
Pielak et al. [8].
In conclusion, the results we have reported above are of
interest since they show that a yeast iso-1 type cyt c can be
readily double-labeled for 3D NMR investigations, and that
quantum chemical calculations (DFT) can be used to help
clarify, at least in some cases, questions about spectroscopic
assignments which might otherwise be more costly and time-
consuming to obtain.
Acknowledgements: We are grateful to Professor A.G. Mauk (Univer-
sity of British Columbia) for providing the pBTR2 plasmid and to
Professor G.S. Rule (Carnegie Mellon University) who provided the
HBHA(CBCA)NH pulse sequence ¢le. We thank Dr. Feng Lin (Uni-
vesity of Illinois at Urbana-Champaign) for assistance with experi-
mental NMR setup. NMR spectra were obtained in the Varian Ox-
ford Instrument Center for Excellence in NMR Laboratory. Funding
for this instrumentation was provided in part from the W.M. Keck
Foundation, the National Institutes of Health (PHS 1 S10 RR10444-
01), and the National Science Foundation (NSF CHE 96-10502). The
National Center for Supercomputing Applications computational
time was funded in part by the National Computational Science Alli-
ance, NSF Grant MCA-98N039N. This work was supported by the
United States Public Health Service (National Institutes of Health
Grants HL-19481 and GM-50694).
Table 1 (continued)
Residue Amide 1H Amide 15N 13C‡ 13CK 13CL 1HK, 1HK2 a 1HL1, 1HL2 a
Thr69 7.41 115.8 174.6 66.7 68.6 3.82 4.17
Asn70 6.78 108.9 173.7 52.7 37.7 4.89 3.21, 3.10
Pro71 178.0 68.0 33.8 5.56
Ala72 9.13 117.4 179.7 54.8 19.0 5.10 2.11
Lys73 7.79 116.4 177.6 57.9 33.8 4.45 2.11, 2.03
Tyr74 8.22 120.6 176.5 62.2 40.9 4.70 4.09, 3.88
Ile75 9.40 115.1 171.0 59.9 38.4 4.72 3.32
Pro76 179.1 64.5 31.5 5.10 2.6, 2.1
Gly77 9.36 112.0 176.2 45.0 3.90, 4.6
Thr78 8.97 115.1 173.4 62.0 70.2 5.07 5.70
Lys79 8.05 122.9 175.0 55.3 32.0 4.79 1.70, 1.36
Met80 8.67 122.3 173.9 67.3
Ala81 8.09 139.0 175.0b 51.9 16.9 5.07 1.27
Phe82 8.56 122.6 175.4b 58.0 42.5 4.7
Glu88 177.5 60.2 29.5 3.42 1.98
Lys89 8.53 116.7 177.7 59.6 32.4 3.82 1.8, 1.56
Asp90 6.24 115.5 177.9 56.9 40.2 4.04 2.63, 2.21
Asn91 7.23 117.7 177.5 61.2 30.2 3.28 1.85, 1.3
Asn92 8.49 117.7 179.6 56.1 37.0 4.4 2.84, 2.6
Asp93 8.49 125.1 177.6 58.9 40.0 4.05 2.5
Leu94 8.14 120.4 178.8 58.7 41.2 3.82 1.38, 1.30
Ile95 8.71 119.8 176.2 66.2 37.2 3.07 1.76
Thr96 7.93 117.4 176.8 68.3 3.70 4.2
Tyr97 7.62 119.5 176.1 61.5 37.9 4.05 3.52, 2.89
Leu98 8.97 119.8 179.1 57.5 42.8 3.24 1.45, 1.26
Lys99 8.51 120.8 177.0 59.1 31.3 3.36 1.43, 1.18
Lys100 6.50 115.5 178.7 57.3 32.4 4.15 1.8
Ala101 8.30 119.5 178.7 54.1 18.9 4.02 0.67
Thr102 7.34 102.6 173.2 61.4 70.0 4.63 4.82
Glu103 6.81 126.4 181.5 58.5 30.8 4.06 2.32, 2.00
aNot stereospeci¢cally assigned.
bTentative assignments.
Fig. 3. Graph showing correlation between experimental threonine
15N chemical shifts and DFT theoretical shieldings for BPTI and
ubiquitin (a) and cyt c (R, U) : slope =30.73, R2 = 0.78. See text
for details.
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